Avazzia devices deliver ultra-precise micro-current electrical stimulation that interacts directly with the body's own bioelectrical signals — producing rapid, lasting pain relief for even the most stubborn chronic conditions.
Overview
Avazzia technology is a sophisticated form of biofeedback-assisted microcurrent stimulation. Unlike conventional TENS devices that simply block pain signals, Avazzia devices actually communicate with the body's own nervous system — detecting its electrical responses and continuously adapting the signal to maintain optimal therapeutic effect. This prevents the nervous system from habituating to the signal, which is why results are often dramatic and lasting.
How It Works
The Avazzia device delivers low-frequency, high-peak-power micro-current impulses that interact with cell membrane receptors, stimulating the production of neuropeptides — the body's own pain-relieving and healing molecules. The device senses the body's response and automatically adjusts its output to maintain therapeutic benefit throughout the session.
Key Benefits
- Stimulates production of natural pain-relieving neuropeptides
- Effective for chronic pain that hasn't responded to other treatments
- Non-invasive and drug-free
- Can be used over injured areas immediately post-injury
- Cumulative effect — results improve with each session
- Can be used as a standalone or combined with other therapies
Conditions Treated
What to Expect
Avazzia sessions last 15–30 minutes. The device is applied to the skin over and around the pain area. Most patients experience significant pain reduction during or immediately after the first session. A series of 6–12 sessions is typically recommended for lasting results.
Avazzia is particularly valuable for patients with severe, complex chronic pain conditions who have exhausted other options. It has produced remarkable results for patients with CRPS, neuropathy, and other notoriously difficult-to-treat conditions.
